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1. Introduction
The mammalian immune system is comprised of two branches of immune 
system; innate and adaptive, which render tolerance towards host for protection 
from microbial infections. The innate immune system consists of functionally 
distinct mechanism that evolved to render protection against pathogens. The 
nonadaptive immune system senses pathogens through pattern recognition recep-
tors which trigger the activation of antimicrobial defense system to stimulate and 
provoke the efficient immune response. The acquired immune system in response 
activates the nonadaptive immune effector mechanisms in an antigen-specific and 
dependent manner. Although the link between various immune components are not 
fully understood, recent progresses bring us closer to an integrated view of immune 
system and its function towards the host defense [1].
The infectious diseases are the leading cause for the greater rate of morbidity and 
mortality world-wide and are a major challenge for the biomedical sciences. The 
physical methods such as improved sanitary conditions, clean water supplies and 
vector control are by far the most effective measures, development of vaccines and 
therapeutics are panacea for their treatment. The development of vaccine and thera-
peutic interventions require the understanding of host immune system. Recently, 
significant progress has been made towards unraveling the mechanisms of microbial 
pathogenesis and host-microbe symbiosis. There are many challenges remain and 
most daunting is the development of effective vaccine. Indeed, it is not known how 
to elicit protective immunity against most pathogens in a safe and practical man-
ner. To address and overcome the autoimmune response mounted by the host are 
required and to be explored by the basic science researchers.
The innate immune system is the phylogenically oldest component of the human 
immune system. The innate immune system is highly complex and consists of 
barriers to infection (epithelia of skin, gastrointestinal, respiratory, genitourinary 
tracts), antimicrobial peptides and proteins, humoral components (i.e., comple-
ment and opsonins) and cellular components (i.e., neutrophils, monocytes/macro-
phages, dendritic cells, and innate lymphoid cells). Innate immunity serves as the 
front line of host defense and plays an essential role in preventing infection while 
tolerating normal host flora. The defects in innate immunity are associated with 
invasive, life-threatening infection, and inappropriate activation of innate immune 
system may lead to auto-inflammatory states. The innate immune system directs the 
subsequent development of adaptive immune responses [2].
The human acquired immune system is responsible for the destruction of 
foreign particles once they have entered the body. During the first exposure to an 
invader (which could be a virus, a bacteria or any unwanted particle), the acquired 
immune system must “learn” how to attack and destroy the foreign particle. This 
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implies that adaptive system is not as active and efficient in the clearance of any 
pathogens as innate immune system [3].
Activation of acquired immune system: unlike the innate immune system, the 
acquired immune system needs to be exposed with a substance before its effective 
action. The acquired immune system is target specific and takes its own time to 
prepare to act against pathogens [3].
1.1  Role of cytokines in the immune response activation and 
immunomodulation
Cytokines participate in many physiological processes including the regulation 
of immune and inflammatory responses. These effector molecules are produced 
transiently and locally and control the quantum of amplitude and duration of the 
response. The research outcomes have shown that meagre or suboptimal production 
of these informational molecules may significantly contribute to the pathophysiol-
ogy of various diseases [4]. Particularly the cytokines released by CD4+ T cells at the 
onset of an immune response are decisive for pathological or physiological conse-
quences. IL-1, IL-4, IL-6, IL-10, IL-12, TNF-alpha and IFN-alpha, -beta, -gamma, 
etc., are known to contribute to the pathophysiology of autoimmune diseases, 
infectious diseases, and allograft rejection [4].
The inflammatory responses in the peripheral and central nervous systems 
play key roles in the development and persistence of many pathological pain states 
[5]. Cytokine a broader name which includes lymphokine; cytokines secreted by 
the lymphocytes, monokines are secreted by the cells of myeloid origin such as 
monocytes, chemokine shows chemotactic activities, and the interleukins are the 
cytokines made by one leukocyte which acts on other leukocytes. The cytokines 
may act on the cells that secrete them in an autocrine manner or on nearby cells fol-
lowing the paracrine fashion. The action in some instances on distant cells is termed 
as “endocrine action” [6].
1.2 Pro-inflammatory cytokines
An inflammatory or pro-inflammatory cytokine is a type of signaling molecule 
that is excreted by the cells of immune cells such as helper T cells (Th) and mac-
rophages, and some other cell types which are known to promote inflammation as 
a defense mechanism. The interleukin-1 (IL-1), IL-12, and IL-18, tumor necrosis 
factor (TNF), interferon gamma (IFN-γ), and granulocyte-macrophage colony 
stimulating (GM-CSF) factor and play an important role in mediating and regulat-
ing the nonadaptive immune response. The inflammatory cytokines are predomi-
nantly produced by and involved in the upregulation of inflammatory reactions to 
show resistance towards infectious pathogen [7, 8].
1.3 Anti-inflammatory cytokines
The anti-inflammatory cytokines are a series of immunoregulatory molecules 
that control pro-inflammatory cytokines, production and their response. The cyto-
kines act in concert with specific cytokine inhibitors and soluble cytokine receptors 
with an objective to regulate the human immune response. Their physiologic role in 
provoking inflammatory responses and pathologic role in systemic inflammatory 
states are increasingly recognized. The chief anti-inflammatory cytokines include 
interleukin (IL)-1 receptor antagonist, IL-4, IL-6, IL-10, IL-11, and IL-13. The 
specific cytokine receptors for IL-1, tumor necrosis factor-α and IL-18 also function 
as the inhibitors of the pro-inflammatory cytokines [9, 10].
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1.4 Immunomodulation
Mesenchymal Stem Cells (MSCs) emerging as key players in regenerative medi-
cine for the treatment of various inflammatory and infectious diseases. The MSCs 
are emerging an effective tool in developing therapeutic interventional approaches 
and further advancements. Several tissues have been identified as potential sources 
of MSCs including bone marrow, cord blood, dental pulp, umbilical cord, adipose 
tissue, peripheral blood, fetal liver, of which some are clinically recognized. MSCs 
activate the immune responses and inhibit proliferation, maturation and differen-
tiation of T and B cells. The MSCs activated immune response induce the expres-
sion of regulatory T cells (Tregs) [11] which are very important in regulating the 
immune system and immune effecters of diseased cells.
The immune response activation and immunomodulation is an essential reading 
to all medical students, biologist, biochemist, and professionals involved in the field 
of immunology of infectious diseases and beyond. The book is a useful and ideal 
guide for novice researchers interested in learning research methods to unravel the 
knot of immune responses and their activation. The role of various cytokines in 
mounting the protective/immune response as well as during immunomodulation is 
the central theme of this book.
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